Financial reports
10-Q
2017 Q3
Quarterly report
7 Nov 17
10-Q
2017 Q2
Quarterly report
8 Aug 17
10-Q
2017 Q1
Quarterly report
1 May 17
10-K
2016 FY
Annual report
14 Mar 17
10-Q
2016 Q3
Quarterly report
7 Nov 16
10-Q
2016 Q2
Quarterly report
9 Aug 16
10-Q
2016 Q1
Quarterly report
10 May 16
10-K
2015 FY
Annual report
14 Mar 16
10-Q
2015 Q3
Quarterly report
9 Nov 15
10-Q
2015 Q2
Quarterly report
10 Aug 15
Current reports
8-K
Termination of a Material Definitive Agreement
8 Feb 18
8-K
Departure of Directors or Certain Officers
28 Dec 17
8-K
Tender and Support Agreement
22 Dec 17
8-K
Ignyta Announces Third Quarter 2017
7 Nov 17
8-K
Ignyta Announces Proposed Public Offering of Common Stock
20 Oct 17
8-K
Regulation FD Disclosure
18 Oct 17
8-K
Ignyta Receives European Medicines Agency Prime Designation for Entrectinib
17 Oct 17
8-K
Ignyta Provides Update on Entrectinib ANDRXDX-105 at the Esmo 2017 Congress
11 Sep 17
8-K
Ignyta Provides Regulatory Update on Entrectinib
6 Sep 17
8-K
Departure of Directors or Certain Officers
18 Aug 17
Registration and prospectus
15-12B
Securities registration termination
20 Feb 18
POS AM
Prospectus update (post-effective amendment)
12 Feb 18
POS AM
Prospectus update (post-effective amendment)
12 Feb 18
POS AM
Prospectus update (post-effective amendment)
12 Feb 18
POS AM
Prospectus update (post-effective amendment)
12 Feb 18
POSASR
Automatic shelf registration (post-effective amendment)
12 Feb 18
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 18
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 18
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 18
S-8 POS
Registration of securities for employees (post-effective amendment)
12 Feb 18
Other
EFFECT
Notice of effectiveness
22 Feb 18
EFFECT
Notice of effectiveness
22 Feb 18
EFFECT
Notice of effectiveness
22 Feb 18
EFFECT
Notice of effectiveness
22 Feb 18
CT ORDER
Confidential treatment order
31 May 17
EFFECT
Notice of effectiveness
21 Apr 16
EFFECT
Notice of effectiveness
21 Apr 16
CORRESP
Correspondence with SEC
19 Apr 16
CORRESP
Correspondence with SEC
19 Apr 16
CT ORDER
Confidential treatment order
18 Apr 16
Ownership
SC 13G/A
Ignyta, Inc.
15 Feb 18
SC 13G/A
Ignyta, Inc.
14 Feb 18
SC 13G/A
Ignyta, Inc.
14 Feb 18
SC 13G/A
Ignyta, Inc.
14 Feb 18
SC 13G/A
Ignyta, Inc.
13 Feb 18
4
James L Freddo
12 Feb 18
4
William R McCarthy
12 Feb 18
4
Heiner Dreismann
12 Feb 18
4
Jonathan E Lim
12 Feb 18
4
James A Bristol
12 Feb 18